Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Open in API
Filings indexed 553 across all filing types
Latest filing 2021-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for HLB Co., Ltd. for the period ending March 31, 2021. It contains detailed financial information, company history, capital structure, and management details, which are characteristic of a comprehensive interim financial report. It is not a mere announcement or certification, as it provides substantive financial data and business analysis. Q1 2021
2021-05-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status of a major shareholder (Jin Yang-gon) and related parties in HLB Co., Ltd., including changes in share collateral agreements. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-04-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement titled '정기주주총회결과' (Annual General Meeting Results) for HLB, dated 2021-03-30. It details the outcomes of the meeting, including the approval of financial statements, director appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-03-30 Korean
대표이사변경
Board/Management Information Classification · 1% confidence The document is a formal regulatory announcement regarding a change in the company's representative director (CEO). It details the transition from a single representative to a co-representative structure, provides the effective date, board resolution details, and biographical information for the new appointee. This aligns perfectly with the definition for Board/Management Information (MANG).
2021-03-30 Korean
타법인주식및출자증권취득결정(자율공시)
M&A Activity Classification · 1% confidence The document is a regulatory filing from HLB (에이치엘비) regarding the acquisition of shares in another company (Verismo Therapeutics, Inc.). The title '타법인주식및출자증권취득결정' (Decision to acquire shares and equity securities of another corporation) clearly indicates an M&A-related activity or strategic investment. Since it details the acquisition of equity in another entity, it falls under the M&A Activity category.
2021-03-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of an individual (Kim, Yong Ung) who is an executive at HLB Co., Ltd. This type of filing is a standard regulatory requirement for insiders to disclose their personal share transactions or changes in ownership, which corresponds to the 'Director's Dealing' category.
2021-03-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.